Inspire Medical Systems, Inc. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA). The company's proprietary Inspire system is the first FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. Unlike traditional continuous positive airway pressure (CPAP) therapy, Inspire therapy works inside the body with the patient's natural breathing process to keep the airway open during sleep. The system consists of an implantable pulse generator (neurostimulator), a pressure-sensing lead, and a stimulation lead, controlled by a patient remote. The company is currently transitioning to its next-generation Inspire V system, which integrates sensing capabilities directly into the neurostimulator, eliminating the need for a separate pressure-sensing lead.

Research as of 19 Jun 2026